AI assistant
Sending…
MUSTANG BIO, INC. — Director's Dealing 2018
Nov 6, 2018
35167_dirs_2018-11-05_0f4c15d0-85ee-4451-bab3-0946a6db4ac1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2018-11-02
Reporting Person: ROSENWALD LINDSAY A MD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-02 | COMMON STOCK | P | 50000 | $4.41 | Acquired | 70000 | Direct |
Footnotes
F1: Includes 20,000 restricted stock units which vest over time.
More from MUSTANG BIO, INC.
Interim / Quarterly Report
2026
May 5
Delisting Announcement
2026
Apr 17
Major Shareholding Notification
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Director's Dealing
2025
Dec 30
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Proxy Solicitation & Information Statement
2025
Dec 3
Interim / Quarterly Report
2025
Nov 7